Disease Course and Response to Immunotherapy in Children With Childhood Disintegrative Disorder: A Retrospective Case

Meghan I Sullivan1, Megha J Gupta2, Kathryn A Taylor3

  • 1Duke University School of Medicine, Durham, NC, USA.

Journal of Child Neurology
|December 20, 2023
PubMed

Insights

Childhood disintegrative disorder (CDD) shows severe developmental regression. Immunotherapy showed varied responses in CDD patients, suggesting its natural history may mimic treatment effects.

Area of Science:

  • Neurobehavioral disorders
  • Pediatric neurology
  • Autoimmune encephalitis

Background:

  • Childhood disintegrative disorder (CDD) is a rare neurodevelopmental disorder with profound regression in language, social behavior, and adaptive functions.
  • The etiology of CDD is unknown, and current treatments focus on symptom management.
  • Similarities exist between CDD and pediatric autoimmune encephalitis, prompting investigation into neuroinflammatory mechanisms.

Purpose of the Study:

  • To investigate the potential role of immunotherapy in children diagnosed with childhood disintegrative disorder.
  • To explore the diagnostic overlap and treatment response between CDD and possible autoimmune encephalitis.

Main Methods:

  • Retrospective review of 5 children with CDD initially treated with immunotherapy for possible autoimmune encephalitis.
  • Inclusion of a sixth patient with CDD who experienced spontaneous improvement.

Main Results:

  • Two of the 5 children treated with immunotherapy showed significant improvement.
  • Three children with CDD did not show significant changes with immunotherapy.
  • The sixth patient's spontaneous improvement highlighted the variable natural history of CDD.

Conclusions:

  • Immunotherapy yields variable results in children with CDD, complicating the assessment of treatment efficacy.
  • The natural history of CDD can mimic treatment responsiveness, underscoring the need for careful diagnostic evaluation.
  • Further research is needed to elucidate the underlying mechanisms of CDD and identify effective treatments.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
945
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
25
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
456
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
251
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
68